Biomarkers in dysplasia of the oral cavity: A systematic review

Oral Oncology

Volumn 45, Issue 8, 2009, Pages 647-653

  Smith, Joel ^a   Rattay, Tim ^a   McConkey, Chris ^a   Helliwell, Tim ^b   Mehanna, Hisham ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Allelic instability; Biomarkers; Cathespin L mRNA; DNA ploidy; Genetic markers; Loss of heterozygosity; Matrix metalloproteinase mRNA; Oral dysplasia; p53; p73; Survivin; Systematic review

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN L; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEIN P53; PROTEIN P73; SURVIVIN;

CANCER RISK; DATA BASE; DISEASE COURSE; DNA CONTENT; DYSPLASIA; ERYTHROPLASIA; FOLLOW UP; GENE LOCUS; GENETIC DISORDER; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; LEUKOPLAKIA; MOUTH CANCER; MOUTH CAVITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; GENETIC MARKERS; HUMANS; MOUTH; MOUTH DISEASES; PRECANCEROUS CONDITIONS;

EID: 67650450845     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.02.006     Document Type: Review

References (52)

1. Silverman S., Gorsky M., and Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 53 (1984) 563-568
2. Pindborg J.J., Reichart P., Smith C.J., and van der Waal I. World Health Organisation: histological typing of cancer and precancer of the oral mucosa (1997), Springer-Verlag, Berlin
3. Leon Barnes, John W. Eveson, Peter Reichart, David Sidransky, editors. Pathology and Genetics of Head and Neck Tumours. World Health Organization Classification of Tumours 2005.
4. Karabulut A., Reibel J., Therkildsen M.H., Praetorius F., Neilson H.W., and Dabelsteen E. Observer variability in the histological assessment of oral premalignant lesions. J Oral Pathol Med 24 (1995) 198-200
5. Abbey L.M., Kaugars G.E., Gunsolley J.C., et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Med 80 (1995) 188-191
6. Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological and molecular biological characteristics. Crit Rev Oral Biol Med 14 1 (2003) 46-47
7. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September 2006]. In: The Cochrane library, issue 4. Chichester, UK: John Wiley and Sons, Ltd.; 2006.
8. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of non randomised studies in meta-analyses. .
9. Sudbø J., Ried T., Bryne M., Kildal W., et al. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol 37 7 (2001) 558-565
10. Sudbø J., Kildal W., Risberg B., Koppang H.S., et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 344 17 (2001) 1270-1278
11. Sudbø J., Bryne M., Johannessen A.C., Kildal W., et al. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol 194 3 (2001) 303-310
12. Zhao J., Gua B., Ma S.C., and Zhou X.D. Expression of p53 and Ki67 genes in epithelial dysplasia from old oral mucosa and clinical significance. Sichuan Da Xue Xue Bao Yi Xue Ban 36 5 (2005) 689-691
13. Shahnavaz S.A., Bradley G., Regezi J.A., Thakker N., et al. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas. Cancer Res 61 6 (2001) 2371-2375
14. Kilpi A., Rich A.M., Konttinen Y.T., Reade P.C., et al. Expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus and subsequent squamous cell carcinoma. Eur J Oral Sci 104 3 (1996) 278-284
15. Kudo Y., Takata T., Ogawa I., Sato S., et al. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep 6 3 (1999) 539-545
16. Kudo Y., Takata T., Ogawa I., Zhao M., et al. Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 151 2 (2000) 217-222
17. Ogden G.R., Lane D.P., and Chisholm D.M. p53 Expression in dyskeratosis congenita: a marker for oral premalignancy?. J Clin Pathol 46 2 (1993) 169-170
18. Chen Y.S., Wang J.T., Chang Y.F., Liu B.Y., et al. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 33 4 (2004) 209-217
19. Soni S., Mathur M., Shukla N.K., and Deo S.V. Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 107 2 (2003) 309-316
20. Soni S., Kaur J., Kumar A., Chakravarti N., et al. Alterations of Rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 68 4-6 (2005) 314-325
21. Varma D., Gupta S., and Mandal A.K. Role of p53 and bcl2 as markers of vitamin A response in premalignant lesions of the oral cavity. Indian J Pathol Microbiol 50 1 (2007) 15-17
22. Xie X., Clausen O.P., Sudbö J., and Boysen M. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer 79 11 (1997) 2200-2208
23. Ralhan R., Chakravarti N., Kaur J., Sharma C., et al. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators. Int J Cancer 118 5 (2006) 1077-1089
24. Kodani I., Shomori K., Osaki M., Kuratate I., et al. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology 69 3 (2001) 150-158
25. Hamidi S., Salo T., Kainulainen T., Epstein J., et al. Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer 82 8 (2000) 1433-1440
26. Lee J.J., Hong W.K., Hittelmann W.N., Mao L., Lotan R., Shin D.M., et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6 (2000) 1702-1710
27. Auclair P.L. Altered H-antigen reactivity as an early indicator of malignant transformation in oral epithelium. J Oral Pathol 13 4 (1984) 401-411
28. Seoane J., Bascones A., Asenjo J., Garcia-pola M., et al. Flow cytometric analysis of nuclear DNA content in oral leukoplakia. Clin Otolaryngol 23 (1998) 136-140
29. Schoelch M.L., Regezi J.A., Dekker N.P., and Ng I.O.L. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35 (1999) 333-342
30. Neppelberg E., and Johannessen A.C. DNA content, cyclooxygenase and loss of E-cadherin expression do not predict malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol 264 (2007) 1223-1230
31. Abdel-Salam M., Mayall B.H., Chew K., Silverman Jr. S., et al. Which oral white lesions will become malignant? An image cytometric study. Oral Surg Oral Med Oral Pathol 69 3 (1990) 345-350
32. Chen Y.K., Hsue S.S., and Lin L.M. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 34 4 (2005) 232-239
33. Lin C.Y., Hung H.C., Kuo R.C., Chiang C.P., and Kuo M.Y. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Oral Oncol 41 6 (2005) 645-654
34. Kerdpon D., Rich A.M., and Reade P.C. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 3 (1997) 86-92
35. Mao L., Lee J.S., Fan Y.H., Ro J.Y., et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2 6 (1996) 682-685
36. Partridge M., Pateromichelakis S., Phillips E., Emilion G.G., et al. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 60 14 (2000) 3893-3898
37. Rautava J, Soukka T, Inki P, Leimola-Virtanen R, et al. CD44v6 in developing and malignant oral epithelia. Oral Oncol 2003;39:373-9.
38. Murti P.R., Warnakulasuria K.A.A.S., Johnson N.W., Bhonsle R.B., Gupta P.C., Daftary D.K., et al. p53 Expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 27 (1998) 191-196
39. Rosin M.P., Lam W.L., Poh C., Le N.D., et al. 3p14 And 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62 (2002) 6447-6450
40. Rich A.M., Kerdpon D., and Reade P.C. p53 Expression in oral precancer and cancer. Aust Dent J 44 2 (1999) 103-105
41. Shahnavaz S.A., Regezi J.A., Bradley G., Dube I.D., and Jordan R.C.K. p53 Gene mutations in sequential oral epithelial dysplasias and squamous cell carcinoma. J Pathol 190 (2000) 417-422
42. Regezi J.A., Zarbo R.J., Regev E., Pisanty S., et al. p53 Protein expression in sequential biopsies of oral dysplasias and in situ carcinomas. J Oral Pathol Med 24 1 (1995) 18-22
43. Cruz I.B., Snijders P.J., Meijer C.J., Braakhuis B.J., Snow G.B., Walboomers J.M., et al. p53 Expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184 (1998) 360-368
44. Cruz I., Napier S.S., van der Wall I., Snijders P.J.F., Walboomers J.M.M., Lamey P.J., et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 55 (2002) 98-104
45. Högmo A., Lindskog S., Lindholm J., Kuylenstierna R., et al. Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res 18 5B (1998) 3645-3650
46. Chen Y.K., Hsue S.S., and Lin L.M. p73 Expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?. Head Neck 26 (2004) 945-952
47. Jordan R.C.K., Macabeo-Ong M., Shiboki C.H., Dekker N., Ginzinger D.G., Wong D.T.W., et al. Overexpression of matrixmetalloproteinase-1 and 9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10 (2004) 6460-6465
48. Macabeo-Ong M., Shiboki C.H., Silverman S., Dekker N., Ginzinger D.G., Wong D.T.W., et al. Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol 39 7 (2003) 638-647
49. Lo Muzio L., Pannone G., Leonardi R., Staibano S., Mignogna M.D., Rosa G.D., et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 82 11 (2003) 923-928
50. Partridge M., Emilion G., Pateromichelakis S., A'Hern R., Phillips E., and Langdon J. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol 34 (1998) 77-83
51. Rosin M.P., Cheng X., Poh C., Lam W.L., Huang Y., Lovas J., et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6 (2000) 357-362
52. Zhou X., Jordan R.C.K., Li Y., Haung B.L., and Wong T.W. Frequent allelic imbalances at 8p and 11p22 in oral and oropharyngeal epithelial dysplastic lesions. Can Gen Cytogen 161 (2005) 86-89